查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679371

霧化器市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2025 年至 2030 年

Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By Application (COPD, Asthma, Cystic Fibrosis), By End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

霧化器市場的成長與趨勢

根據 Grand View Research, Inc. 的最新報告，全球霧化器市場規模預計到 2030 年將達到 17.7 億美元，2025 年至 2030 年的複合年成長率為 6.35%。

慢性呼吸系統疾病盛行率上升、居家醫療設備需求增加以及全球老齡人口成長是推動市場成長的主要因素。

COVID-19 疫情已影響全球數百萬人。患有氣喘和慢性阻塞性肺病 (COPD) 的患者意識到 COVID-19 透過空氣傳播的風險，因此不願使用吸入藥物，因為吸入藥物被認為可能會增加病毒傳播並抑制免疫系統。然而，全科醫生鼓勵所有此類患者繼續使用複方吸入藥物，包括霧化器。在美國某些地區，當藥局面臨吸入性沙丁胺醇短缺時，建議使用霧化沙丁胺醇作為沙丁胺醇救援藥物的替代品。

COVID-19 影響了許多老年人。根據美國肺臟協會 (ALA) 2020 年的報告，霧化治療是 COVID-19 期間患者在家中治療 COPD 的安全有效的方法。這反過來又推動了對霧化器的需求。

根據人口問題實驗室的報告《美國的老化》，美國老年人口數量預計將從2016年的4,800萬人增加到2060年的9,800萬人。老年人更容易患慢性阻塞性肺病和睡眠呼吸中止症等呼吸系統疾病。因此，老年人口的增加有望擴大製造商的患者群並推動市場成長。

此外，由於網狀霧化器能夠精確地向肺部輸送藥物，且殘留量較少，其商業性接受度不斷提高，這也推動了市場的成長。此外，藥物-設備組合等技術進步有望為霧化器市場創造新的機會。

然而，霧化過程中的藥物損失是限制市場成長的主要因素。然而，這也可能為網狀霧化器製造商帶來機會，因為它們的製造目的是提供精確的藥物劑量，同時最大限度地減少藥物損失。

霧化器市場報告重點

  • 按類型分類，噴射霧化器部分佔據 2024 年最大收入佔有率，為 64.82%。
  • 由於技術先進的緊湊型設備以及最少的藥物損失，預計網狀霧化器類型部分在預測期內將表現出良好的複合年成長率。
  • 按應用分類，慢性阻塞性肺病(COPD) 領域在 2024 年佔據了最大的市場佔有率。這是由於 COPD 在世界各地的盛行率很高，而且最近的技術進步使得霧化器更加便攜且易於使用。
  • 2024年，醫院部門佔最大收益佔有率，為67.25%。這是由於優惠的報銷政策和大量的患者客流量。
  • 2024 年，北美佔了最大的收益佔有率，為 34.06%。氣喘、慢性阻塞性肺病(COPD) 和支氣管炎等呼吸系統疾病很普遍，推動了市場的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章霧化器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 霧化器市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析
    • 法律規範
    • 新興科技趨勢
    • COVID-19影響分析

第 4 章 霧化器市場：按類型進行估計和趨勢分析

  • 細分儀表板
  • 全球霧化器市場類型變化分析
  • 2018 年至 2030 年全球霧化器市場規模及趨勢分析（按類型）
  • 噴射霧化器
  • 網狀霧化器
    • 主動網狀霧化器
    • 被動式網狀霧化器
  • 超音波霧化器

第5章 霧化器市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 全球霧化器市場應用變化分析
  • 2018-2030 年全球霧化器市場規模及應用趨勢分析
  • 慢性阻塞性肺病
  • 囊腫纖維化
  • 氣喘
  • 其他

第 6 章霧化器市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 全球霧化器市場最終用途趨勢分析
  • 2018-2030年全球霧化器市場規模及趨勢分析（依最終用途）
  • 醫院和診所
  • 急診中心
  • 居家醫療

第7章霧化器市場：區域、估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024 年公司市場佔有率/地位分析
  • 公司簡介/上市公司
    • OMRON Corporation
    • GE Healthcare
    • Koninklijke Philips NV
    • Vectura Group Plc.
    • PARI Respiratory Equipment, Inc.
    • Aerogen
    • DeVilbiss Healthcare LLC
    • Beurer GmBH
    • Microlife Corporation
    • GF Health Products, Inc.
    • Rossmax International Ltd.
    • BESCO MEDICAL LIMITED
    • Bremed Ltd.
Product Code: GVR-2-68038-069-9

Nebulizer Market Growth & Trends:

The global nebulizer market size is estimated to reach USD 1.77 billion by 2030, registering a CAGR of 6.35% from 2025 to 2030, according to a new report by Grand View Research, Inc., Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware regarding the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced shortage of albuterol inhalers.

COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. Consequently, promotes the nebulizers demand.

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

Increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth. Furthermore, Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market.

On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss.

Nebulizer Market Report Highlights:

  • By type, the jet nebulizers segment held the largest revenue share of 64.82% in 2024, owing to the low cost of the devices.
  • Mesh nebulizers type segment is expected to witness lucrative CAGR over the forecast period, due to the technologically advanced compact size devices and minimized drug loss.
  • Based on application, the chronic obstructive pulmonary disorder (COPD) segment accounted for the largest market share in 2024, owing to the high global prevalence of COPD, recent technological advancements have made nebulizers more portable and user-friendly.
  • In 2024, the hospitals segment accounted for the largest revenue share of 67.25% in 2024, owing to the favorable reimbursement policies and significant patient footfall.
  • North America held the largest revenue share of 34.06% in 2024. Respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and bronchitis have become more prevalent, thereby contributing to market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Nebulizers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic respiratory diseases
      • 3.2.1.2. Growing demand for home healthcare products
      • 3.2.1.3. Increasing availability of advanced and cost-effective technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Drug loss during drug delivery
      • 3.2.2.2. Risk of disease transmission
      • 3.2.2.3. Stringent regulatory requirements
  • 3.3. Nebulizers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Emerging Technology Trends
    • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Nebulizers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Nebulizers Market Type Movement Analysis
  • 4.3. Global Nebulizers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Jet Nebulizer
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Mesh Nebulizer
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Active Mesh Nebulizer
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Passive Mesh Nebulizer
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Ultrasonic Nebulizer
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Nebulizers Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Nebulizers Market Application Movement Analysis
  • 5.3. Global Nebulizers Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. COPD
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cystic Fibrosis
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Asthma
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. ebulizers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Nebulizers Market End Use Movement Analysis
  • 6.3. Global Nebulizers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital and Clinics
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Emergency Centers
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Home Healthcare
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Nebulizers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. OMRON Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. GE Healthcare
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Koninklijke Philips N.V.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Vectura Group Plc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. PARI Respiratory Equipment, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Aerogen
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. DeVilbiss Healthcare LLC
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Beurer GmBH
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Microlife Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. GF Health Products, Inc.,
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Rossmax International Ltd.
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. BESCO MEDICAL LIMITED
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Bremed Ltd.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 24 UK nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 30 France nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 31 France nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 52 China nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 53 China nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 58 India nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 59 India nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Nebulizers market: Market outlook
  • Fig. 5 Nebulizers market: Segment outlook
  • Fig. 6 Nebulizers market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Nebulizers market driver impact
  • Fig. 9 Nebulizers market restraint impact
  • Fig. 10 Nebulizers market: Type outlook and key takeaways
  • Fig. 11 Nebulizers market: Type movement analysis
  • Fig. 12 Jet nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Active mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Passive mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Ultrasonic nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Nebulizers market: Application outlook and key takeaways
  • Fig. 18 Nebulizers market: Application movement analysis
  • Fig. 19 COPD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cystic fibrosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Nebulizers market: End use outlook and key takeaways
  • Fig. 24 Nebulizers market: End use movement analysis
  • Fig. 25 Hospital and Clinics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 Emergency Centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Home Healthcare market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 28 Global nebulizers market: Regional outlook and key takeaways
  • Fig. 29 Global nebulizers market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Key country dynamics
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)